Sarah Slabaugh DO
Child & Adolescent Psychiatry
Consult/Liaison Child and Adolescent Psychiatry, Baystate Children's Hospital
Join to View Full Profile
3300 Main StreetSpringfield, MA 01107
Dr. Slabaugh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Sarah Slabaugh is a psychiatrist in Springfield, MA. She received her medical degree from Philadelphia College of Osteopathic Medicine. She specializes in child & adolescent and interventional psychiatry. She has 1 publication and 7 citings.
Education & Training
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Child and Adolescent Psychiatry, 2021 - 2023
California Institute of Integral StudiesCertificate, Psychedelic Therapy and Research , 2020 - 2021
John Peter Smith Hospital (Tarrant County Hospital District)Residency, Psychiatry, 2018 - 2021- Suburban Community HospitalInternship, Internal Medicine, 2017 - 2018
Philadelphia College of Osteopathic MedicineClass of 2017
Certifications & Licensure
TX State License 2018 - 2026
MA State License 2023 - 2025
PA State License 2017 - 2018
American Board of Psychiatry and Neurology Psychiatry- American Board of Psychiatry and Neurology Child & Adolescent Psychiatry
Publications & Presentations
PubMed
- Suicide after psychedelic-assisted treatment in context.M Earleywine, Zachary Herrmann, Sarah Slabaugh
Psychiatry Research. 2025-04-01 - 3 citationsPsychedelic Use Among Psychiatric Medication Prescribers: Effects on Well-Being, Depression, Anxiety, and Associations with Patterns of Use, Reported Harms, and Transf...Zachary Herrmann, Adam W Levin, Steven P Cole, Sarah Slabaugh, Brian Barnett
Psychedelic Medicine. 2023-09-01 - 13 citationsScoping Review of Experiential Measures from Psychedelic Research and Clinical Trials.Zachary Herrmann, Mitch Earleywine, Joseph De Leo, Sarah Slabaugh, Timothy Kenny
Journal of Psychoactive Drugs. 2022-09-20
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
